Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agios Pharmaceuticals, Inc. - Common Stock (NQ: AGIO )

31.07 -0.91 (-2.85%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 443,655
Open 32.00
Bid (Size) 30.89 (1)
Ask (Size) 31.56 (1)
Prev. Close 31.98
Today's Range 31.02 - 32.50
52wk Range 27.14 - 62.58
Shares Outstanding 58,951,469
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Agios Pharmaceuticals Reveals Encouraging Data From Rare Blood Disorder Study In Younger Patients Aged Below 18 Years
Agios' mitapivat met its primary endpoint in a Phase 3 trial for PK deficiency in children. The company plans a marketing application based on the results. 
Via Benzinga
Earnings Scheduled For February 13, 2025
Via Benzinga

Performance

YTD
-2.42%
-2.42%
1 Month
-4.87%
-4.87%
3 Month
-18.60%
-18.60%
6 Month
-30.83%
-30.83%
1 Year
+3.57%
+3.57%

More News

Read More
Tesla, Micron, Broadcom, MARA Holdings And Other Big Stocks Moving Higher On Monday
Via Benzinga
Analyst Ratings For Agios Pharmaceuticals
Via Benzinga
Agios Crashes 19% After A Surprise Side Effect Hammered Its 'Very Safe' Drug
Via Investor's Business Daily
Deep Dive Into Alnylam Pharmaceuticals Stock: Analyst Perspectives (6 Ratings)
Via Benzinga
Earnings Preview: Agios Pharmaceuticals
Via Benzinga
4 Analysts Have This To Say About Agios Pharmaceuticals
Via Benzinga
Expert Ratings For Agios Pharmaceuticals
Via Benzinga
This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Via Benzinga
Micron To $150? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit.
Via Investor's Business Daily
Agios Pharmaceuticals' Rare Blood Disorder Drug Misses Primary Goal In Pediatric Study, Stock Slides
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Novavax And Agios Pharmaceuticals Were Among The 10 Biggest Mid-Cap Gainers Last Week (June 1-June 7): Are These In Your Portfolio?
Via Benzinga
June’s Biotech Boom: 3 Stocks to Buy for a Summertime Surge
Via InvestorPlace
Why Is Agios Pharmaceuticals Stock Trading Higher On Monday?
Via Benzinga
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
Via Benzinga
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Nvidia Again Boosts Nasdaq To Record Highs
Via Talk Markets
Topics Stocks
Exposures US Equities
Why Is Agios Pharmaceuticals Stock Trading Higher On Tuesday?
Via Benzinga
Exposures Product Safety
Nvidia, Insmed, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Agios Pharmaceuticals Inks $905 Million Deal For Cancer Drug; Shares Poised To Break Out
Via Investor's Business Daily
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Attention Biotech Investors - Stocks To Watch
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.